You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. The impact of METTL3 on bladder cancer through m6A modification: a potential therapeutic target and prognostic biomarker
- 2. Assessment of prostate cancer aggressiveness through the combined analysis of prostate MRI and 2.5D deep learning models
- 3. Prognostic value of lymph node ratio in patients with non-small cell lung cancer: a systematic review and meta-analysis
- 4. Aspirin a day keeps bowel cancer at bay
- 5. Scientists uncover immune cells that help prostate cancer resist treatment — and reveal a way to stop them
- 6. Top biotech deals in June 2025
- 7. Expression of Insulin-like growth factor 2 mRNA-binding protein 3 and its diagnostic value in breast cancer
- 8. Breast cancer survivors may have lower risk of developing Alzheimer's disease, study finds
- 9. The fatal mutation that lets cancer outsmart the human immune system
- 10. Health Check: Promedicus shares smash record $300 barrier on back of mega deals
Last updated at 21:39 GMT
Hot News Makers
Health/Pharma Companies
-
123698.19
-
41112.17
-
28440.22
-
15273.89
-
10454.86
-
6582.03
-
6100.46
-
5582.23
-
5274.64
-
4846.11
Drugs, Treatments, Trials
-
129043.00
-
15339.73
-
9658.03
-
8009.35
-
6052.89
-
5952.03
-
4539.11
-
3649.19
-
3174.74
-
2843.11
Last updated at 21:10 GMT
